LD-2 disclosure · 1st Quarter - Termination
GENENTECH
Client
- Name
- GENENTECH
- Description
- Biotechnology company
- Location
- District of Columbia · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues related to drug pricing. Issues related to the 340B Drug Discount Program. Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues relating to privacy and securing the data of and personal information of consumers General education on policies effecting development of pharmaceuticals, FDA approval and reimbursement.
LobbyistsNICK KOLOVOS · mr MATTHEW LAWRENCE BERZOK
Covered position (NICK KOLOVOS): LA and Counsel, Rep. Anna Eshoo
Covered position (mr MATTHEW LAWRENCE BERZOK): LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues related to drug pricing. Issues related to the 340B Drug Discount Program. Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease;
LobbyistsNICK KOLOVOS · mr MATTHEW LAWRENCE BERZOK
Covered position (NICK KOLOVOS): LA and Counsel, Rep. Anna Eshoo
Covered position (mr MATTHEW LAWRENCE BERZOK): LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch